Updated COPD-X guide reflects stronger evidence for triple therapy

Stronger evidence for triple therapy in COPD patients with exacerbations has driven one of the changes in the latest update of the Lung Foundation’s COPD-X Concise Guide. The Guide, endorsed by the TSANZ and the RACGP, says the combination of ICS / LABA / LAMA results in a lower rate of moderate or severe COPD ...

Already a member?

Login to keep reading.

© 2021 the limbic